Inhalation |
a |
|
ADD, average daily dose; C
g+p, concentration
of VMS in gaseous and aerosolized states (μg/m3);
IR, inhalation rate (m3/day); EF, exposure frequency (days);
ED, exposure duration (years), F
uptaken, uptake fraction; BW, body weight (kg); AT, average time (day). |
|
b |
|
E, exposure; C, concentration
in air (μg/m3); IRair, inhalation rate
for adults (1.2 m3/h); AT, average time for 8 h per day
spent in this industrial area (h); F
uptaken, uptake fraction. |
|
c |
|
DED, daily exposure dose; C, concentration
in air (μg/m3); IR, inhalation rate (m3/day); ED, exposure duration (years); BW, body weight (kg). |
|
d |
|
E, exposure; Fuptaken, uptake fraction; Cair, concentration
in air (μg/m3); V
air
, volume of inhalation (m3/day); C
PM2.5, concentration in PM2.5(μg/g); Q
PM2.5, PM2.5 inhalation rate (g/d);
BW, body weight (kg). |
|
e |
|
Inhexp, the daily inhalation exposure per
capita; C
air, concentration in air (μg/m3); V
room, indoor air volume (m3); IR, inhalation rate (20 m3/day for adults and
5 m3/day for children); ED, exposure duration (day); BW,
average
body weight (kg). |
|
Oral ingestion |
f |
|
EDI, estimated daily intakes; C, concentration
in dust (ng/g); ED, exposure duration (years); IR, dust ingestion
rate (20 and 50 mg/day for adults and children with a normal exposure
case, 50 and 200 mg/day for adults and children with a high exposure
case); EF, exposure frequency (day/year); BW, average body weight
(kg); AT, average time (day). |
|
g |
|
ADD, average daily dose; C, concentrations
of VMS (μg/g); ED, exposure duration (years); EF, exposure frequency
(days); F
ing, uptake fraction of the compound; Q, dust ingestion rate (g/day); BW, body weight (kg); AT,
average time (day). |
|
h |
|
EDI, estimated daily intakes; C, concentration
of VMS (ng/g); R, daily dust intake rate (g/d); P
time, percentage of the time that people spent
in measured regions; BW, average body weight (kg). |
|
i |
|
EDI, estimated daily intakes; C, concentration
of VMS (ng/g); R, daily dust intake rate (g/d); IEF,
indoor exposure fraction (h/day); BW, average body weight (kg). |
|
j |
|
E, exposure
via ingestion; Cdust, concentration of
VMS in indoor dust (μg/g); Q
dust, dust ingestion rate (g/day). |
|
k |
|
EDI, estimated daily intakes; C, concentration
of VMS (ng/g); W, daily intake rate (g/d); BIO, bioavailability,
1; BW, average body weight (kg). |
|
l |
|
E, mouthing exposure; C,
concentration of VMS in children’s products (μg/g); W, weight of the entire product; Bio, bioavailability, 1;
MF, VMS in the product that can migrate to saliva; BW, body weight
(kg). |
|
Dermal exposure |
m |
|
DED, dermal exposure dose; C, concentration
of VMS (μg/g); ABS, dermal adsorption fraction; AF, skin adherence
factor (mg/cm2); SA, exposed surface area of skin (cm2/day); EF, exposure frequency (day/year); BW, average body
weight (kg); CF, conversion factor (106 mg/kg). |
|
n |
|
EDI, estimated daily intakes; C, concentration
of VMS (μg/g); ABS, dermal adsorption fraction (0.03); AF, skin
adherence factor (0.07 and 0.2 mg/cm2 for adults and children);
SA, exposed surface area of skin (5700 and 2700 cm2 for
adults and children, respectively); EF, exposure frequency (day/year);
ED, exposure duration (years); BW, average body weight (kg); AT, average
time (day). |
|
o |
|
ADD, average daily dose; i, type of PCPs; C
PCPs, concentrations PCPs (μg/g); EF,
exposure frequency (days); ED, exposure duration (years); F
der, fraction of the product that may be retained
on the skin surface; A, amount of product used per
application (g/event); F
q
, frequency of application (events/day); R, retention
factor; BW, body weight (kg); AT, average time (day). |
|